ONZETRA

Drug Avanir Pharmaceuticals, Inc.
Total Payments
$13,689
Transactions
83
Doctors
58
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $13,669 82 57
2018 $19.58 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,000 12 80.4%
Consulting Fee $1,285 6 9.4%
Food and Beverage $958.48 62 7.0%
Travel and Lodging $440.71 2 3.2%
Education $4.31 1 0.0%

Top Doctors Receiving Payments for ONZETRA — Page 3

Doctor Specialty Location Total Records
, D.O Neurology Englewood, CO $12.46 1
, MD Internal Medicine Chicago, IL $11.72 1
, MD Internal Medicine Chicago, IL $11.72 1
Joseph Pagano Tallahassee, FL $11.70 1
, M.D Pain Medicine Cleveland, OH $11.48 1
, MD Pain Medicine Salem, VA $11.26 1
, M.D Internal Medicine Tulsa, OK $10.97 1
, MD Internal Medicine New York, NY $4.31 1

About ONZETRA

ONZETRA is a drug associated with $13,689 in payments to 58 healthcare providers, recorded across 83 transactions in the CMS Open Payments database. The primary manufacturer is Avanir Pharmaceuticals, Inc..

Payment data is available from 2018 to 2019. In 2019, $13,669 was paid across 82 transactions to 57 doctors.

The most common payment nature for ONZETRA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,000, 80.4% of total).